Quantcast
Last updated on April 20, 2014 at 19:30 EDT

Latest Genisphere LLC Stories

2014-02-10 08:27:12

HATFIELD, Pa., Feb. 10, 2014 /PRNewswire/ -- Genisphere LLC reported today it has been granted a US patent for a novel strand-specific library preparation method for next generation sequencing based on its proven RNA amplification technology. The new patented process enables amplification and library preparation from clinically relevant RNA samples, adapts easily to a variety of sequencing instruments and systems, and reduces the time required for sample preparation by eliminating...

2013-10-07 12:26:27

HATFIELD, Pa., Oct. 7, 2013 /PRNewswire/ -- Genisphere LLC reported today it has adapted its 3DNA(®) Nanotechnology for use as a universal signal amplification system for improving the sensitivity and overall performance of rapid diagnostic tests and applications. Detailed in a patent application submitted on August 16(th), the new process is a further enhancement of the 3DNA(®) Signal Amplification technology, and eliminates the need for custom chemical modification of antibodies...

2013-08-06 08:33:30

WOONSOCKET, R.I., Aug. 6, 2013 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and Genisphere LLC will collaborate on the development of targeted MCT-485 nanoparticle therapeutics for the treatment of liver cancer. MCT-485 is a noncoding double stranded micro RNA (miRNA) which has demonstrated oncolytic and immune stimulating activity in in vitro models of hepatocellular carcinoma. Hepatocellular carcinoma is the most common form of primary liver cancer, and...